rs61741137
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000356392.9(ODAD3):āc.173T>Cā(p.Phe58Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 1,614,158 control chromosomes in the GnomAD database, including 162 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
ENST00000356392.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODAD3 | NM_145045.5 | c.173T>C | p.Phe58Ser | missense_variant | 1/13 | ENST00000356392.9 | NP_659482.3 | |
ODAD3 | NM_001302454.2 | c.173T>C | p.Phe58Ser | missense_variant | 1/11 | NP_001289383.1 | ||
ODAD3 | XM_017026241.2 | c.173T>C | p.Phe58Ser | missense_variant | 1/9 | XP_016881730.1 | ||
ODAD3 | NM_001302453.1 | c.82+846T>C | intron_variant | NP_001289382.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ODAD3 | ENST00000356392.9 | c.173T>C | p.Phe58Ser | missense_variant | 1/13 | 1 | NM_145045.5 | ENSP00000348757 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00738 AC: 1123AN: 152168Hom.: 5 Cov.: 33
GnomAD3 exomes AF: 0.00855 AC: 2133AN: 249532Hom.: 17 AF XY: 0.00892 AC XY: 1208AN XY: 135384
GnomAD4 exome AF: 0.0127 AC: 18553AN: 1461872Hom.: 157 Cov.: 31 AF XY: 0.0126 AC XY: 9151AN XY: 727234
GnomAD4 genome AF: 0.00737 AC: 1122AN: 152286Hom.: 5 Cov.: 33 AF XY: 0.00658 AC XY: 490AN XY: 74470
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 16, 2020 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | ODAD3: BP4, BS1, BS2 - |
Primary ciliary dyskinesia 30 Benign:2
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 13, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at